Oxidative Stress Measured by Urine F2-Isoprostane Level is Associated With Prostate Cancer
Daniel A. Barocas(Vanderbilt University Medical Center), Jay H. Fowke(Vanderbilt University Medical Center), Jason D. Morrow(University of Ulster), Ginger L. Milne(Vanderbilt University), Michael S. Cookson(University of Oklahoma Health Sciences Center), Qi Dai(Sun Yat-sen University), L. Jackson Roberts(The University of Melbourne), Joseph A. Smith(King's College London), Sam S. Chang(Vanderbilt University), David F. Penson(Geriatric Research Education and Clinical Center), Saundra Motley(Vanderbilt University Medical Center), Raoul S. Concepcion(Integra (United States))
Cited by 91
Related Papers
The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
|New England Journal of Medicine|2003|2k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Increase in Circulating Products of Lipid Peroxidation (F<sub>2</sub>-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage
|New England Journal of Medicine|1995|1.3k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975